Semaglutide is a GLP-1 receptor agonist that has been structurally modified to improve stability and extend its activity in research settings. These molecular changes allow the compound to remain active for longer periods in laboratory studies, making it commonly examined in metabolic research.
 
Semaglutide is supplied for laboratory research purposes only and is not approved for human or animal use.